Diagnosis of Structural Heart Disease Using MCG

Structural Heart Abnormality Clinical Trial

Official title:
Accurate Identification of Structural Heart Disease Using Magnetocardiography as an Innovative and Non-invasive Tool

Status Not yet recruiting

Clinical Trial Summary

The purpose of this prospective cohort study is to determine the parameters of cardiac magnetic imaging to identify structural heart disease using use transthoracic echocardiography or cardiac magnetic resonance as reference standard.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06315998
Study type	Observational
Source	Qilu Hospital of Shandong University
Contact	Jiaojiao Pang
Phone	0086-0531-82165398
Email	jiaojiaopang@126.com
Status	Not yet recruiting
Phase
Start date	March 18, 2024
Completion date	September 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03429452` - The SALMANTICOR Study
Recruiting	`NCT04787757` - Autonomous Robotics for Transcatheter Cardiac Procedures
Not yet recruiting	`NCT06462989` - Harnessing ECG Artificial Intelligence for Rapid Treatment and Accurate Interpretation, an Open Label Randomized Controlled Trial	N/A
Recruiting	`NCT05696522` - Stereotactic Ablative Radiotherapy for the Treatment of Refractory Ventricular Tachycardia	N/A
Recruiting	`NCT06137885` - REgiStry-based Cardiovascular qUality improvEment Research